glp 1 drugs metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia Weight Loss-GLP-1 – Prepared Physician
Description
Glucagon Suppression: They suppress the release of glucagon, a hormone that raises blood sugar levels

Claire Machin, the industry bodys executive director of international policy and UK competitiveness, said developing drugs was a high-risk process, with the average cost of taking a medicine from discovery to launch put at $2.3bn last year

On May 30, Novo Nordisk announced that it was filing lawsuits against spas, clinics, pharmacies, and companies for "unlawful marketing" of compounded drugs, some of which allegedly did not contain semaglutide

It is important to note that Mounjaro is not licensed for type 1 diabetes or diabetic ketoacidosis

I think this is an overblown concern
